The Endocrine Disruptor Page HomeSitemap
 

Chemical Safety Office
Evaluation and Licensing Division
Pharmaceutical and Food Safety Bureau
Ministry of Health, Labor and Welfare

Japanese

Last updated date: March 30, 2015
 

Home

 Advisory Committee

   Actions

     Scheme

     Overview

FAQs

Bisphenol A

Reports, etc.

Related reports

Links

Contact


 
Reports

Advisory Committee on Health Effects of Endocrine Disruptors
The Supplement II to the Intermediary Report
1.2.1-2

 

contents  Detailed contents  << prev  next >>

Section 2: Sampling and analysis
  1. Introduction
Bisphenol A used as a resin monomer, phthalic acid esters used as plasticizers, and alkylphenols used for manufacture of surfactants are attracting public attention for their high exposure levels. Risk analysis for these substances needs the estimation of exposure to humans in addition to the evaluation of effects on organisms.
For this purpose, a high-sensitivity measurement method of human samples and basic studies on acquisition and storage of samples are needed. As in other microanalytical processes, contamination of the sample before the measurement must be prevented.
For the three analytes mentioned above existing in biological samples, a high-sensitivity analytical procedure was developed, and a guideline for analysis of endocrine disruptors in biological samples was established.
While the biological effects of endocrine disruptors are generally evaluated by in vivo experiments on animals, it has been pointed out that effects on animals of exposure to chemicals via the raising and experimental environment (feed, litter, water bottle, air, etc.) should be understood for reliable estimation of the low-dose effects.
Accordingly an analytical method was developed for determining phytoestrogens, in addition to the abovementioned three substances, in animal feeds and other materials in the environment. Its application to actual samples has started.

2. Guideline for determination of endocrine disruptors in foods
The temporary guideline prepared by the then Sampling and Analysis Working Group was published in the Supplement to the Interim Report (December 2001).
No information that would necessitate revision of the guideline has since been found.

contents  Detailed contents  << prev  next >>

 

 

About links, copyright, etc. Privacy policy

(C) 2005, 2016 Ministry of Health, Labour and Welfare, All Rights Reserved.